Recombinant Anti-HCV C Intrabody [Tat]

Recombinant anti-HCV C intrabody in fusion with HIV Tat works within cells to bind HCV C, expressed in E. coli cells. Intracellular immunization represents a promising antiviral approach to interfere with the life cycle of HCV.
Supplier Creative Biolabs
Product # IAB-B075(T)
Pricing Inquiry
Host human
Target HCV C
Species Reactivity HCV
Type scFv-Tat
Applications Products can be used for: Protein fragment complementation; Neutralization; Functional studies
Storage Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.
Feedback